Canada markets close in 2 hours 52 minutes

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.50450.0000 (0.00%)
As of 12:33PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.5045
Open0.4979
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5045 - 0.5045
52 Week Range0.2130 - 0.8820
Volume3,100
Avg. Volume609
Market Cap17.034M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar. 08, 2016
1y Target EstN/A
  • CNW Group

    COVID-19 Pandemic - The government presents its daily update

    QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.

  • Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus
    Newsfile

    Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

    Toronto, Ontario--(Newsfile Corp. - November 16, 2020) -  Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that Canntab and Exactus, Inc. have mutually agreed to terminate the supply and distribution agreements previously announced on November 20, 2019, after determining that the regulatory requirements could not be completed on a timely basis.During a time ...

  • Newsfile

    Canntab Announces Closing of Purchases of Cannabis Processing Equipment and Leasehold Improvements

    Toronto, Ontario--(Newsfile Corp. - October 19, 2020) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the previously announced asset purchase agreement with CMAX Technologies Inc. ("CMAX"), a related party of the Company has closed (the "CMAX Transaction"). Pursuant to the CMAX Transaction, Canntab has acquired certain cannabis-processing ...